Nintx and CNPEM partner to exponentialize natural products from the Brazilian biodiversity as a platform for the generation of multi-target therapies

Nintx and CNPEM will collaborate on the research of natural products as starting points to develop novel therapies for multifactorial diseases (multi-target therapies)

Nintx and Brazilian Center for Research in Energy and Materials (CNPEM) partner to exponentialize natural products from the Brazilian biodiversity as a platform to develop novel therapies for multifactorial diseases (multi-target therapies). Nintx and CNPEM will initially collaborate on the discovery stage of four projects, selected as the most promising for the multi-target approach. “CNPEM holds a library of natural products from bioprospection, in partnership with Phytobios Pesquisa Desenvolvimento e Inovação, advanced screening and analytical technologies, X-ray crystallography using hashtag Sirius, and a team of high caliber scientists. Nintx, with its know-how in research and development, will perfectly complement our Discovery Platform”, said Dr. Kleber Franchini, Director, LNBio-CNPEM. “CNPEM is a worldwide reference in science with an extraordinary ability in drug discovery aiming at finding active compounds from natural origin against biological targets of interest. The idea is to couple this expertise with our proprietary technologies in the human microbiome field”, stated Dr. Cristiano R. W. Guimaraes, CSO, Nintx.

To have access to the full content, check us out on LinkedIn.

https://www.linkedin.com/feed/update/urn:li:activity:6848959215634026496/